Alan Freedman’s practice focuses on a broad range of antitrust matters, including merger review, litigation, counseling, and government investigations.

He has represented clients in federal and state courts, as well as in investigations by the U.S. Department of Justice, Federal Trade Commission, and foreign competition authorities.

Alan joined the firm in 2016 and became a partner in 2024. Before law school, he worked on antitrust litigation and merger reviews at NERA Economic Consulting.

Read More

Notable Experience

Litigation and Investigations

  • Equifax Workforce Solutions in class action litigation pending in the Eastern District of Pennsylvania related to alleged monopolization of income and employment verification services.

  • Keurig in monopolization litigation centralized in the Southern District of New York brought by multiple competitors, purported class action plaintiffs, and individual purchasers, as well as Keurig’s pursuit of counterclaims alleging false and misleading advertising by a competitor.

  • Medtronic in monopolization litigation brought by a competing medical device manufacturer in the Central District of California.

  • A leading multinational technology firm in connection with several global antitrust investigations, including one by the FTC.

See More

Merger Clearance

  • Keurig Dr Pepper in its acquisition of GHOST.

  • Solventum in its pending $4.1 billion sale of its purification and filtration business to Thermo Fisher Scientific Inc.

  • T-Mobile in its $600 million acquisition of Vistar Media.

  • OpenText in its $2.275 billion sale of its application modernization and connectivity business to Rocket Software.

  • 21st Century Fox in U.S. antitrust review of its $71.3 billion sale of its film and television studios and certain cable networks to The Walt Disney Company, as well as in competing bids from Comcast.

  • Essilor in securing unconditional U.S. clearance for its €46 billion combination with Luxottica, owner of Ray-Ban and Oakley.

  • Korean Air Lines in connection with the acquisition of a majority stake in the other leading global airline carrier based in Korea, Asiana Airlines.

  • A genetics company in obtaining the closure with no action taken of a DOJ investigation into its acquisition of a competitor.

See More

Selected Activities

trigger
  • Managing Editor, The University of Chicago Law Review

Publications

Events